1. Home
  2. VUZI vs VYGR Comparison

VUZI vs VYGR Comparison

Compare VUZI & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vuzix Corporation

VUZI

Vuzix Corporation

HOLD

Current Price

$2.55

Market Cap

246.0M

Sector

Technology

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.39

Market Cap

222.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VUZI
VYGR
Founded
1997
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
246.0M
222.4M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
VUZI
VYGR
Price
$2.55
$3.39
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$17.00
AVG Volume (30 Days)
1.1M
631.7K
Earning Date
03-12-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,310,001.00
$31,316,000.00
Revenue This Year
$5.53
N/A
Revenue Next Year
$110.00
$71.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.47
$2.65
52 Week High
$4.82
$5.55

Technical Indicators

Market Signals
Indicator
VUZI
VYGR
Relative Strength Index (RSI) 41.80 33.95
Support Level $2.46 $3.36
Resistance Level $2.75 $3.91
Average True Range (ATR) 0.18 0.23
MACD -0.00 -0.04
Stochastic Oscillator 39.26 4.64

Price Performance

Historical Comparison
VUZI
VYGR

About VUZI Vuzix Corporation

Vuzix Corp is engaged in the design, manufacture, and marketing of Artificial Intelligence (AI)-powered Smart Glasses, Waveguides, and Augmented Reality (AR) technologies. Its solutions serve the enterprise, medical, defense, security, and select consumer markets, offering cutting-edge wearable computing and display technologies that enhance productivity and operational efficiency. Its products include near-eye displays (NEDs), heads-up displays (HUDs), and wearable computing devices. Geographically, the company generates a majority of its revenue from the United States and also has a presence in Japan, the Netherlands, and other countries.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: